Avenue Therapeutics Inc. (NASDAQ: ATXI)
$3.44
-0.0400 ( -1.15% ) 35.6K
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
Market Data
Open
$3.44
Previous close
$3.48
Volume
35.6K
Market cap
$3.28M
Day range
$3.35 - $3.63
52 week range
$3.21 - $91.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 05, 2023 |
4 | Insider transactions | 1 | Jul 05, 2023 |
4 | Insider transactions | 2 | Jul 05, 2023 |